EUVIMEDEUVIMED entdecken
Fallbericht

Roxadustat combined with immunosuppressants for treatment of pure red cell aplasia with kidney injury

Lulu Fan, Lujia Cao, Yangyan Luo, Fang Gao

Annals of Hematology · 2024

DOI: 10.1007/s00277-024-06053-8 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Annals of Hematology, 2024. Verfasst von Lulu Fan und 3 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Chengdu Medical College, Chengdu, China. Hauptthemen laut MEDLINE: Red-Cell Aplasia, Pure, Immunosuppressive Agents, Glycine, Isoquinolines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 6 Literaturangaben. Gefördert von: Sichuan medical research youth innovation project, Chengdu Jinniu District Medical Association kidney special topic key project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pure red cell aplasia is a rare condition that may be congenital or associated with an underlying disease.Immunosuppressants are a commonly employed therapeutic option for the treatment of pure red cell aplasia;however, they are associated with considerable adverse effects, including nephrotoxicity. This case report describesa 74-year-old patient with pure red cell aplasia who developed long-term kidney injury following cyclosporinetherapy. Renal anemia is a common complication after chronic kidney injury and contributes to the poor outcome ofanemia treatment. Following a series of medication adjustments, the final treatment with roxarestat combined withsirolimus proved effective in delaying the impairment of this patient's kidney function, with the hemoglobin levelremaining above 100 g/L throughout. This case report demonstrates the efficacy of roxarestat in conjunction with animmunosuppressive agent in the treatment of pure red cell aplasia combined with kidney injury, with a dual effect ofalleviating the anemia and reducing serum creatinine levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Red-Cell Aplasia, PureImmunosuppressive AgentsGlycineIsoquinolinesHumansAgedMaleCyclosporineDrug Therapy, Combination

Stichwörter der Autor:innen

Chronic kidney diseaseHaemoglobinPure red cell aplasiaRoxadustatSirolimus

Substanzen

Immunosuppressive AgentsroxadustatGlycineIsoquinolinesCyclosporine

Autor:innen und Institutionen

  • The First Affiliated Hospital of Chengdu Medical College, Chengdu, China.
  • The First Affiliated Hospital of Chengdu Medical College, Chengdu, China. 158468931@qq.com.

Förderung

  • Sichuan medical research youth innovation project
  • Chengdu Jinniu District Medical Association kidney special topic key project

Zitieren

APA

Fan, L., Cao, L., Luo, Y., & Gao, F. (2024). Roxadustat combined with immunosuppressants for treatment of pure red cell aplasia with kidney injury. Annals of Hematology. https://doi.org/10.1007/s00277-024-06053-8

Vancouver

Fan L, Cao L, Luo Y, Gao F. Roxadustat combined with immunosuppressants for treatment of pure red cell aplasia with kidney injury. Annals of Hematology. 2024. doi:10.1007/s00277-024-06053-8

BibTeX
@article{Fan2024,
  author = {Fan, Lulu and Cao, Lujia and Luo, Yangyan and Gao, Fang},
  title = {Roxadustat combined with immunosuppressants for treatment of pure red cell aplasia with kidney injury},
  journal = {Annals of Hematology},
  year = {2024},
  doi = {10.1007/s00277-024-06053-8}
}
Kostenlos starten →